Bg pattern

TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ticagrelor Sandoz 60 mg Film-Coated Tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Ticagrelor Sandoz and what is it used for
  2. What you need to know before you take Ticagrelor Sandoz
  3. How to take Ticagrelor Sandoz
  4. Possible side effects
  5. Storage of Ticagrelor Sandoz
  6. Contents of the pack and other information

1. What is Ticagrelor Sandoz and what is it used for

What is Ticagrelor Sandoz

Ticagrelor Sandoz contains the active substance ticagrelor. It belongs to a group of medicines called antiplatelet agents.

What Ticagrelor Sandoz is used for

Ticagrelor in combination with acetylsalicylic acid (another antiplatelet agent) should only be used in adults. You have been prescribed this medicine because you have had:

  • a heart attack more than a year ago.

This medicine reduces the risk of you having another heart attack, a stroke, or dying from a heart or blood vessel disease.

How Ticagrelor Sandoz works

Ticagrelor works on cells called platelets (also called thrombocytes). These very small blood cells help stop bleeding by clumping together to block tiny holes in blood vessels that are cut or damaged.

However, platelets can also form clots inside damaged blood vessels in the heart and brain. This can be very dangerous because:

  • the clot can completely block the blood flow; this can cause a heart attack (myocardial infarction) or a stroke, or
  • the clot can partially block the blood vessels that go to the heart; this reduces blood flow to the heart and can cause intermittent chest pain (called unstable angina).

Ticagrelor helps prevent platelets from clumping together. This reduces the chance of a blood clot forming that could block blood flow.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Ticagrelor Sandoz

Do not take Ticagrelor Sandoz

  • if you are allergic to ticagrelor or any of the other ingredients of this medicine (listed in section 6),
  • if you have a current bleeding disorder,
  • if you have had a stroke caused by bleeding in the brain,
  • if you have severe liver disease,
  • if you are taking any of the following medicines:
    • ketoconazole (used to treat fungal infections),
    • clarithromycin (used to treat bacterial infections),
    • nefazodone (an antidepressant),
    • ritonavir and atazanavir (used to treat HIV and AIDS).

Do not take ticagrelor if you are in any of the above situations. If you are unsure, consult your doctor or pharmacist before taking this medicine.

Warnings and precautions

Consult your doctor or pharmacist before taking ticagrelor if:

  • you have a higher risk of bleeding due to:
    • a recent severe injury,
    • a recent surgical procedure (including dental procedures, ask your dentist about this),
    • a disorder that affects blood clotting,
    • a recent stomach or intestine bleeding (such as stomach ulcer or colon polyps),
  • you need to have surgery (including dental procedures) at any time while taking ticagrelor. This is because it increases the risk of bleeding. Your doctor may want to stop your treatment with this medicine 5 days before surgery,
  • your heart rate is abnormally slow (normally less than 60 beats per minute) and you do not have a device that regulates your heart (pacemaker),
  • you have asthma or other lung problems or breathing difficulties,
  • you develop irregular breathing patterns, such as rapid, slow, or brief pauses in breathing. Your doctor will decide if you need any further evaluation,
  • you have had any liver problems or have had a disease that may have affected your liver,
  • you have had a blood test that shows high levels of uric acid.

If any of the above applies to you (or if you are unsure), consult your doctor or pharmacist before taking this medicine.

If you are taking ticagrelor and heparin:

  • your doctor may require a blood sample for diagnostic tests if they suspect the presence of a rare platelet disorder caused by heparin. It is essential that you inform your doctor that you are taking ticagrelor and heparin, as ticagrelor may affect the diagnostic test.

Children and adolescents

Ticagrelor is not recommended for children and adolescents under 18 years of age.

Other medicines and Ticagrelor Sandoz

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. This is because ticagrelor may affect the way some medicines work and some medicines may affect ticagrelor.

Tell your doctor or pharmacist if you are taking any of the following medicines:

  • rosuvastatin (a medicine used to treat high cholesterol),
  • more than 40 mg daily of simvastatin or lovastatin (medicines used to treat high cholesterol levels),
  • rifampicin (an antibiotic),
  • phenytoin, carbamazepine, and phenobarbital (used to control epilepsy seizures),
  • digoxin (used to treat heart failure),
  • cyclosporin (used to reduce the body's immune response),
  • quinidine and diltiazem (used to treat irregular heart rhythms),
  • beta-blockers and verapamil (used to treat high blood pressure),
  • morphine and other opioids (used to treat acute pain).

In particular, tell your doctor or pharmacist if you are taking any of the following medicines that increase the risk of bleeding:

  • oral anticoagulants, often referred to as blood thinners, including warfarin,
  • non-steroidal anti-inflammatory medicines (NSAIDs) often taken as painkillers, such as ibuprofen and naproxen,
  • selective serotonin reuptake inhibitors (SSRIs) taken as antidepressants, such as paroxetine, sertraline, and citalopram,
  • other medicines such as ketoconazole (used to treat fungal infections), clarithromycin (used to treat bacterial infections), nefazodone (an antidepressant), ritonavir and atazanavir (used to treat HIV and AIDS), cisapride (used to treat stomach acidity), and ergot alkaloids (used to treat migraines and headaches).

Tell your doctor that, because you are taking ticagrelor, you may have a higher risk of bleeding if your doctor gives you fibrinolytics, often referred to as clot dissolvers, such as streptokinase or alteplase.

Pregnancy and breast-feeding

Ticagrelor should not be used if you are pregnant or may become pregnant. Women should use appropriate contraceptive methods to prevent pregnancy while taking this medicine.

Consult your doctor before taking this medicine if you are breast-feeding. Your doctor will explain the benefits and risks of taking ticagrelor during this period.

If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Ticagrelor is not expected to affect your ability to drive or use machines. If you feel dizzy or confused while taking this medicine, be careful while driving or using machines.

Ticagrelor Sandoz contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

3. How to take Ticagrelor Sandoz

Follow exactly the instructions of your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

How much to take

  • the usual dose is one 60 mg tablet twice a day. Keep taking ticagrelor as long as your doctor tells you to,
  • take this medicine at the same time every day (for example, one tablet in the morning and one in the evening).

Taking ticagrelor with other blood clotting medicines

Your doctor will also usually prescribe acetylsalicylic acid. This is a substance found in many medicines used to prevent blood clotting. Your doctor will tell you how much to take (usually between 75-150 mg daily).

How to take ticagrelor

  • you can take this medicine with or without food,
  • you can check when you took your last ticagrelor tablet by looking at the blister pack. A sun symbol (for morning) and a moon symbol (for evening) will appear. This will tell you if you have taken your dose.

If you have difficulty swallowing the tablet

If you have difficulty swallowing the tablet, you can crush it and mix it with water as follows:

  • crush the tablet into a fine powder,
  • pour the powder into half a glass of water,
  • stir and drink immediately,
  • to make sure there is no medicine left, rinse the empty glass with another half a glass of water and drink it.

If you are in the hospital, this tablet may be given to you mixed with a little water through a tube in your nose (nasogastric tube).

If you take more Ticagrelor Sandoz than you should

If you have taken more ticagrelor than you should, consult your doctor immediately or go to the hospital immediately. Bring the medicine pack with you. You may have a higher risk of bleeding.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take ticagrelor

  • if you forget to take a dose, just take your next dose at the usual time,
  • do not take a double dose (two doses at the same time) to make up for forgotten doses.

If you stop taking ticagrelor

Do not stop taking ticagrelor without consulting your doctor. Take this medicine regularly and for as long as your doctor tells you to. If you stop taking ticagrelor, you may increase the risk of having another heart attack or stroke, or dying from a heart or blood vessel disease.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. With this medicine, the following side effects may occur:

Ticagrelor affects blood clotting, so most side effects are related to bleeding. Bleeding can occur anywhere in the body. Some level of bleeding is common (such as bruising and nosebleeds). Severe bleeding is rare but can be life-threatening.

Tell your doctor immediately if you notice any of the following, you may need urgent medical treatment:

  • A bleeding in the brain or inside the skull is an uncommon side effect and can cause signs of a stroke such as:
    • sudden numbness or weakness of the arms, legs, or face, especially if it affects only one side of the body,
    • sudden confusion, difficulty speaking or understanding others,
    • sudden difficulty walking or loss of balance or coordination,
    • sudden feeling of dizziness or severe headache of unknown cause.
  • Signs of bleeding such as:
    • severe or uncontrolled bleeding,
    • unexpected or prolonged bleeding,
    • urine that is pink, red, or brown,
    • vomiting blood or vomit that looks like coffee grounds,
    • black or red stools (like tar),
    • coughing or vomiting blood.
  • Fainting (syncope)
    • temporary loss of consciousness due to a sudden drop in blood flow to the brain (common).
  • Signs of a blood clotting problem called thrombotic thrombocytopenic purpura (TTP) such as:
    • fever and purple spots (called purpura) on the skin and in the mouth, with or without yellowing of the skin or eyes (jaundice), extreme tiredness or confusion.

Tell your doctor if you notice any of the following:

  • Difficulty breathing, this is very common. It may be due to heart disease or another cause, or it may be a side effect of ticagrelor. The breathing difficulty related to ticagrelor is usually mild and is characterized by a sudden, unexpected need for air that occurs normally at rest and may disappear in many cases. If you think your breathing difficulty has worsened or lasts a long time, tell your doctor. They will decide if you need treatment or further investigation.

Other possible side effects

Very common (may affect more than 1 in 10 people)

  • high levels of uric acid in the blood (as seen in blood tests),
  • bleeding caused by blood disorders.

Common (may affect up to 1 in 10 people)

  • bruising,
  • headache,
  • feeling dizzy or as if everything is spinning,
  • diarrhea or indigestion,
  • feeling sick (nausea),
  • constipation,
  • rash,
  • itching,
  • severe pain and swelling in the joints, these are signs of gout,
  • feeling dizzy or faint, or blurred vision, these are signs of low blood pressure,
  • nosebleeds,
  • bleeding more than usual after surgery or cuts (for example, when shaving) and wounds,
  • bleeding from the stomach walls (ulcer),
  • bleeding gums.

Uncommon (may affect up to 1 in 100 people)

  • allergic reaction, a skin rash, itching, swelling of the face or swelling of the lips/tongue may be signs of an allergic reaction,
  • confusion,
  • vision problems caused by bleeding in the eye,
  • heavier or irregular vaginal bleeding, or bleeding between periods,
  • bleeding into the joints and muscles that causes painful swelling,
  • bleeding in the ear,
  • internal bleeding, this can cause dizziness or fainting.

Frequency not known (cannot be estimated from the available data)

  • abnormally low heart rate (normally below 60 beats per minute).

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ticagrelor Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after CAD/EXP. The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Packaging Contents and Additional Information

Composition ofTicagrelor Sandoz

  • The active ingredient is ticagrelor. Each film-coated tablet contains 60 mg of ticagrelor.
  • The other ingredients are:

Tablet core: mannitol (E421), calcium hydrogen phosphate dihydrate, corn starch, pregelatinized corn starch, talc (E553b), stearic acid salt and sodium.

Tablet coating: poly (vinyl alcohol) (E1203), talc (E553b), titanium dioxide (E171), glycerol monocaprylate, sodium lauryl sulfate, red iron oxide (E172), black iron oxide (E172).

Product Appearance and Packaging Contents

Film-coated tablets: the tablets are round, biconvex, pink in color, marked with “60” on one side and smooth on the other, with a diameter of 8.6 mm ± 5%.

Ticagrelor Sandoz is available in:

  • standard blisters (with or without sun/moon symbols) in packs of 10, 14, 20, 56, 60, 100, and 168 tablets,
  • calendar blisters (with or without sun/moon symbols) in packs of 14, 56, and 168 tablets,
  • a multiple pack containing 168 (3 packs of 56), 180 (3 packs of 60), and 200 (4 packs of 50) tablets in standard blisters (with or without sun/moon symbols),
  • a multiple pack containing 168 (3 packs of 56) in calendar blisters (with or without sun/moon symbols).

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Sandoz Farmacéutica, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Lek Pharmaceuticals d.d

Verovskova 57

1526 Ljubljana

Slovenia

or

PharOS MT Ltd.

HF62X, Hal Far Industrial Estate,

Birzebbugia BBG3000,

Malta

Date of Last Revision of this Leaflet:December 2024

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.

Online doctors for TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS

Discuss questions about TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS?
TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS?
The active ingredient in TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS is ticagrelor. This information helps identify medicines with the same composition but different brand names.
Who manufactures TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS?
TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS is manufactured by Sandoz Farmaceutica S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TICAGRELOR SANDOZ 60 mg FILM-COATED TABLETS?
Other medicines with the same active substance (ticagrelor) include BRILIQUE 60 mg FILM-COATED TABLETS, BRILIQUE 60 mg FILM-COATED TABLETS, BRILIQUE 90 mg ORALLY DISINTEGRATING TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media